Vancomycin: Ligand recognition, dimerization and super-complex formation

FEBS Journal

Volumn 280, Issue 5, 2013, Pages 1294-1307

  Jia, Zhiguang ^a   O'Mara, Megan L ^a   Zuegg, Johannes ^a   Cooper, Matthew A ^a   Mark, Alan E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

antibiotic resistance; computer simulation; glycopeptide antibiotics; lipid II; molecular dynamics

Indexed keywords

DIMER; DIMETHYL SULFOXIDE; LIPID; VANCOMYCIN; WATER;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DIMERIZATION; DRUG STRUCTURE; LIGAND BINDING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PREDICTION; PRIORITY JOURNAL; SIMULATION; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; HYDROGEN BONDING; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; VANCOMYCIN;

POSIBACTERIA;

EID: 84874477469     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12121     Document Type: Article

References (50)

1. Diekema DJ, BootsMiller BJ, Vaughn TE, Woolson RF, Yankey JW, Ernst EJ, Flach SD, Ward MM, Franciscus CLJ, Pfaller MA, et al,. (2004) Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 38, 78-85.
2. Kahne D, Leimkuhler C, Lu W, &, Walsh C, (2005) Glycopeptide and lipoglycopeptide antibiotics. Chem Rev 105, 425-448.
3. Loll PJ, &, Axelsen PH, (2000) The structural biology of molecular recognition by vancomycin. Annu Rev Biophys Biomol Struct 29, 265-289.
4. Waltho JP, Williams DH, Stone DJM, &, Skelton NJ, (1988) Intramolecular determinants of conformation and mobility within the antibiotic vancomycin. J Am Chem Soc 110, 5638-5643.
5. Grdadolnik SG, Pristovšek P, &, Mierke DF, (1998) Vancomycin: conformational consequences of the sugar substituent. J Med Chem 41, 2090-2099.
6. Takács-Novák K, Noszál B, Tõkés- Kövesdi M, &, Szász G, (1993) Acid-base properties and proton-speciation of vancomycin. Int J Pharm 89, 261-263.
7. de Kruijff B, van Dam V, &, Breukink E, (2008) Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics. Prostagl Leukotr Ess 79, 117-121.
8. Breukink E, &, de Kruijff B, (2006) Lipid II as a target for antibiotics. Nat Rev Drug Discov 5, 321-323.
9. van Dam V, Sijbrandi R, Kol M, Swiezewska E, de Kruijff B, &, Breukink E, (2007) Transmembrane transport of peptidoglycan precursors across model and bacterial membranes. Mol Microbiol 64, 1105-1114.
10. Vollmerhaus PJ, Breukink E, &, Heck AJR, (2003) Getting closer to the real bacterial cell wall target: biomolecular interactions of water-soluble lipid II with glycopeptide antibiotics. Chemistry 9, 1556-1565.
11. Schäfer M, Schneider TR, &, Sheldrick GM, (1996) Crystal structure of vancomycin. Structure 4, 1509-1515.
12. Nitanai Y, Kikuchi T, Kakoi K, Hanamaki S, Fujisawa I, &, Aoki K, (2009) Crystal structures of the complexes between vancomycin and cell-wall precursor analogs. J Mol Biol 385, 1422-1432.
13. Williams DH, Williamson MP, Butcher DW, &, Hammond SJ, (1983) Detailed binding sites of the antibiotics vancomycin and ristocetin A: determination of intermolecular distances in antibiotic/substrate complexes by use of the time-dependent NOE. J Am Chem Soc 105, 1332-1339.
14. Loll PJ, Miller R, Weeks CM, &, Axelsen PH, (1998) A ligand-mediated dimerization mode for vancomycin. Chem Biol 5, 293-298.
15. Loll PJ, Bevivino AE, Korty BD, &, Axelsen PH, (1997) Simultaneous recognition of a carboxylate-containing ligand and an intramolecular surrogate ligand in the crystal structure of an asymmetric vancomycin dimer. J Am Chem Soc 119, 1516-1522.
16. Loll PJ, Kaplan J, Selinsky BS, &, Axelsen PH, (1999) Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding. J Med Chem 42, 4714-4719.
17. Loll PJ, Derhovanessian A, Shapovalov MV, Kaplan J, Yang L, &, Axelsen PH, (2009) Vancomycin forms ligand-mediated supramolecular complexes. J Mol Biol 385, 200-211.
18. Williams DH, &, Bardsley B, (1999) The vancomycin group of antibiotics and the fight against resistant bacteria. Angew Chem Int Ed 38, 1172-1193.
19. McComas CC, Crowley BM, &, Boger DL, (2003) Partitioning the loss in vancomycin binding affinity for d -Ala- d -Lac into lost H-bond and repulsive lone pair contributions. J Am Chem Soc 125, 9314-9315.
20. Williams DH, Maguire AJ, Tsuzuki W, &, Westwell MS, (1998) An analysis of the origins of a cooperative binding energy of dimerization. Science 280, 711-714.
21. LeTourneau DL, &, Allen NE, (1997) Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics. Anal Biochem 246, 62-66.
22. Linsdell H, Toiron C, Bruix M, Rivas G, &, Menénde M, (1996) Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. J Antibiot 49, 181-193.
23. McPhail D, &, Cooper A, (1997) Thermodynamics and kinetics of dissociation of ligand-induced dimers of vancomycin antibiotics. J Chem Soc, Faraday Trans 93, 2283-2289.
24. Booth PM, &, Williams DH, (1989) Preparation and conformational analysis of vancomycin hexapeptide and aglucovancomycin hexapeptide. J Chem Soc Perkin Trans 1, 2335-2339.
25. Jusuf S, Loll PJ, &, Axelsen PH, (2003) Configurational entropy and cooperativity between ligand binding and dimerization in glycopeptide antibiotics. J Am Chem Soc 125, 3988-3994.
26. Lee JG, Sagui C, &, Roland C, (2005) Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues. J Phys Chem B 109, 20588-20596.
27. Yang Z, Vorpagel ER, &, Laskin J, (2008) Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues. J Am Chem Soc 130, 13013-13022.
28. Jia Z, O'Mara ML, Zuegg J, Cooper MA, &, Mark AE, (2011) The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II. Biophys J 101, 2684-2692.
29. Cristofaro MF, Beauregard DA, Yan H, Osborn NJ, &, Williams DH, (1995) Cooperativity between non-polar and ionic forces in the binding of bacterial cell wall analogues by vancomycin in aqueous solution. J Antibiot 48, 805-810.
30. Kannan R, Harris CM, Harris TM, Waltho JP, Skelton NJ, &, Williams DH, (1988) Function of the amino sugar and N-terminal amino acid of the antibiotic vancomycin in its complexation with cell wall peptides. J Am Chem Soc 110, 2946-2953.
31. O'Brien DP, Entress RMH, Cooper MA, O'Brien SW, Hopkinson A, &, Williams DH, (1999) High affinity surface binding of a strongly dimerizing vancomycin-group antibiotic to a model of resistant bacteria. J Am Chem Soc 121, 5259-5265.
32. Sharman GJ, Try AC, Dancer RJ, Cho YR, Staroske T, Bardsley B, Maguire AJ, Cooper MA, O'Brien DP, &, Williams DH, (1997) The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria. J Am Chem Soc 119, 12041-12047.
33. Sundram UN, Griffin JH, &, Nicas TI, (1996) Novel vancomycin dimers with activity against vancomycin-resistant Enterococci. J Am Chem Soc 118, 13107-13108.
34. Nicolaou KC, Hughes R, Cho SY, Winssinger N, Labischinski H, &, Endermann R, (2001) Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis. Chemistry 7, 3824-3843.
35. Williams DH, &, Waltho JP, (1988) Molecular basis of the activity of antibiotics of the vancomycin group. Biochem Pharmacol 37, 133-141.
36. Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE, et al,. (2005) Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49, 1127-1134.
37. Krause KM, Renelli M, Difuntorum S, Wu TX, Debabov DV, &, Benton BM, (2008) In vitro activity of telavancin against resistant Gram-positive bacteria. Antimicrob Agents Chemother 52, 2647-2652.
38. Judice JK, &, Pace JL, (2003) Semi-synthetic glycopeptide antibacterials. Bioorg Med Chem Lett 13, 4165-4168.
39. Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, Kuipers OP, de Kruijff B, &, Breukink E, (2006) An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636-1637.
40. Hess B, Kutzner C, van der Spoel D, &, Lindahl E, (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4, 435-447.
41. Schmid N, Eichenberger AP, Choutko A, Riniker S, Winger M, Mark AE, &, van Gunsteren WF, (2011) Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J 40, 843-856.
42. Malde AK, Zuo L, Breeze M, Stroet M, Poger D, Nair PC, Oostenbrink C, &, Mark AE, (2011) An automated force field topology builder (ATB) and repository: Version 1.0. J Chem Theory Comput 7, 4026-4037.
43. Berendsen HJC, Postma JPM, van Gunsteren WF, &, Hermans J, (1981) Interaction models for water in relation to protein hydration. In Intermolecular Forces (, Pullman B, ed.), pp. 331-342. Reidel, Dordrecht.
44. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, &, Haak JR, (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81, 3684.
45. Hess B, Bekker H, Berendsen HJC, &, Fraaije JGEM, (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18, 1463-1472.
46. Miyamoto S, &, Kollman PA, (1992) SETTLE: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13, 952-962.
47. Feenstra KA, Hess B, &, Berendsen HJC, (1999) Improving efficiency of large time-scale molecular dynamics simulations of hydrogen-rich systems. J Comput Chem 20, 786-798.
48. Macrae CF, Edgington PR, McCabe P, Pidcock E, Shields GP, Taylor R, Towler M, &, van de Streek J, (2006) Mercury: visualization and analysis of crystal structures. J Appl Crystallogr 39, 453-457.
49. Darden T, York D, &, Pedersen L, (1993) Particle mesh Ewald: An N-log (N) method for Ewald sums in large systems. J Chem Phys 98, 10089.
50. Tironi IG, Sperb R, Smith PE, &, van Gunsteren WF, (1995) A generalized reaction field method for molecular dynamics simulations. J Chem Phys 102, 5451.